Research Collaboration and Licensing

Kyowa Kirin's business vision is fulfilled through diligent and continuous efforts to bring innovative pharmaceuticals to patients, utilizing our R&D expertise and knowledge.
We recognize that accessing and pursuing external opportunities for our R&D activities is an indispensable and essential aspect of our strategy to establish a solid pipeline of products.
We are actively seeking opportunities within the following focused therapeutic areas.
Should you have an opportunity within these areas that you would like to present to us, we would invite you to contact us using the link below. We would be delighted to explore how we can work together to maximize the value of any such opportunity.

We strive to create innovative value in pharmaceuticals by positioning bone & mineral, intractable hematological diseases/hemato oncology, rare diseases as our focused therapeutic areas.

External Research and Collaboration

We deeply believe that "Open Innovation" is essential for drug discovery and actively seek for research collaboration opportunities especially on novel target finding, discovery-to-preclinical stage drug candidates, and innovative technologies for accelerating drug development. We are open and flexible to strategic collaborations or partnerships with pharmaceuticals, biotech, and academia partners.

Licensing and Partnering

For licensing and partnering, we globally and/or regionally explore development and commercialization of products which matches with our disease area of focus (Please see our pipeline and products.)

We have established licensing and partnering with excellent companies.

Kyowa Kirin's PartnersPDF file